Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Uterine Cervical Neoplasms Medicine & Life Sciences
Lymph Nodes Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Squamous Cell Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2018

2 Citations

KPNA2 promotes migration and invasion in epithelial ovarian cancer cells by inducing epithelial-mesenchymal transition via Akt/GSK-3β/Snail activation

Huang, L., Zhou, Y., Cao, X. P., Lin, J. X., Zhang, L., Huang, S. T. & Zheng, M., Jan 1 2018, In : Journal of Cancer. 9, 1, p. 157-165 9 p.

Research output: Contribution to journalArticle

Epithelial-Mesenchymal Transition
Snails
Carcinoma
Western Blotting
karyopherin alpha 2

Loss of MED12 induces tumor dormancy in human epithelial ovarian cancer via downregulation of EGFR

Luo, X. L., Deng, C. C., Su, X. D., Wang, F., Chen, Z., Wu, X. P., Liang, S. B., Liu, J. H. & Fu, L. W., Jul 1 2018, In : Cancer Research. 78, 13, p. 3532-3543 12 p.

Research output: Contribution to journalArticle

Down-Regulation
Neoplasms
Recurrence
RNA Polymerase II
Microarray Analysis
3 Citations

Pazopanib maintenance therapy in east asian women with advanced epithelial ovarian cancer: Results from AGO-OVAR16 and an East Asian study

Kim, J. W., Mahner, S., Wu, L. Y., Shoji, T., Kim, B. G., Zhu, J. Q., Takano, T., Park, S. Y., Kong, B. H., Wu, Q., Wang, K. L., Ngan, H. Y., Liu, J-H., Wei, L. H., Mitrica, I., Zhang, P., Crescenzo, R., Wang, Q., Cox, C. J., Harter, P. & 1 othersDu Bois, A., Jan 1 2018, In : International Journal of Gynecological Cancer. 28, 1, p. 2-10 9 p.

Research output: Contribution to journalArticle

Maintenance
Placebos
Disease-Free Survival
Therapeutics
pazopanib